Company Analysis

Cardiff Oncology, Inc. (CRDF)

Nasdaq: CRDF · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2003
Grade4.4
◀ Past 4.9● Present 3.7▶ Future 4.8
1 est.

Who runs Cardiff Oncology, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mohindru Mani
Chief Executive Officer. First filing Jun 2021, latest Jul 16, 2026, 2 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
26 people on the record since 2012
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Mohindru ManiChief Executive OfficerJun 2021Jul 16, 2026none
Aggarwal AjayChief Operating OfficerApr 2026Apr 28, 2026none
Muntner Joshua BChief Financial OfficerApr 2026Apr 16, 2026none
Smeal TodChief Scientific OfficerJan 2022Apr 16, 2026none
Lindsay Brigitte UteChief Accounting OfficerFeb 2026Feb 18, 2026none
Sidhu RogerChief Medical OfficerJul 2025Jul 8, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Pace Gary WdirectorApr 2020Jul 16, 2026none
Armitage James OdirectorApr 2020Jun 15, 2026none
Markin Rodney SdirectorFeb 2014Jun 15, 2026none
Tannenbaum Renee PdirectorJun 2021Jun 15, 2026none
White LaledirectorApr 2020Jun 15, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CRDF · research, not advice